Robert J. Bitterman

Insider Reports History

Location: Westborough, MA
Signature: /s/ Lisa C. Carson, Attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert J. Bitterman:

Form 4 holding Chairman, Pres. & CEO, Director

Phio Pharmaceuticals Corp.

Security class: Common Stock, $.0001 par value
Shares / value: 411,421
Estimated value: $419,649
Report date: 05 Feb 2026
Price: $1.02
Ownership: Direct

Insider Reports Filed by Robert J. Bitterman

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 05 Feb 2026
Transactions: 1
Transaction value: $0
Filing time: 06 Feb 2026, 07:56
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 31 Dec 2025
Transactions: 1
Transaction value: +$5,150
Filing time: 02 Jan 2026, 16:05
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 23 Dec 2025
Transactions: 1
Transaction value: +$5,100
Filing time: 29 Dec 2025, 08:10
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 21 Nov 2025
Transactions: 1
Transaction value: +$5,700
Filing time: 24 Nov 2025, 12:54
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 18 Nov 2025
Transactions: 1
Transaction value: +$6,350
Filing time: 19 Nov 2025, 12:47
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 11 Sep 2025
Transactions: 2
Transaction value: -$9,538
Filing time: 15 Sep 2025, 08:28
Role: Chairman, Pres. & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 10 Jun 2025
Transactions: 1
Transaction value: +$4,840
Filing time: 11 Jun 2025, 17:00
Role: Chairman, Pres & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 09 Jun 2025
Transactions: 1
Transaction value: +$4,125
Filing time: 10 Jun 2025, 16:43
Role: Chairman, Pres & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 21 May 2025
Transactions: 2
Transaction value: +$7,446
Filing time: 23 May 2025, 09:04
Role: Chairman, Pres & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 11 Sep 2024
Transactions: 1
Transaction value: $0
Filing time: 13 Sep 2024, 14:59
Role: Chairman, Pres & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 07 Jun 2024
Transactions: 1
Transaction value: +$740
Filing time: 11 Jun 2024, 17:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 06 Jun 2024
Transactions: 1
Transaction value: +$750
Filing time: 10 Jun 2024, 17:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 26 Feb 2024
Transactions: 1
Transaction value: +$2,275
Filing time: 27 Feb 2024, 16:42
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 20 Feb 2024
Transactions: 1
Transaction value: -$1,371
Filing time: 22 Feb 2024, 19:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 01 Oct 2023
Transactions: 1
Transaction value: -$1,385
Filing time: 03 Oct 2023, 19:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 30 Jun 2023
Transactions: 2
Transaction value: +$5,720
Filing time: 05 Jul 2023, 18:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 20 Feb 2023
Transactions: 1
Transaction value: $0
Filing time: 22 Feb 2023, 18:00
Role: President & CEO, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 14 Dec 2022
Transactions: 1
Transaction value: +$780
Filing time: 15 Dec 2022, 16:00
Role: Interim Executive Chairman, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 07 Dec 2022
Transactions: 1
Transaction value: +$780
Filing time: 08 Dec 2022, 15:30
Role: Interim Executive Chairman, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 05 Dec 2022
Transactions: 1
Transaction value: +$860
Filing time: 06 Dec 2022, 15:30
Role: Interim Executive Chairman, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 25 Nov 2022
Transactions: 2
Transaction value: +$1,136
Filing time: 29 Nov 2022, 15:30
Role: Interim Executive Chairman, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 16 Nov 2022
Transactions: 1
Transaction value: +$1,750
Filing time: 16 Nov 2022, 16:06
Role: Interim Executive Chairman, Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 01 Oct 2022
Transactions: 1
Transaction value: $0
Filing time: 03 Oct 2022, 20:01
Role: Director
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 15 Feb 2022
Transactions: 1
Transaction value: $0
Filing time: 16 Feb 2022, 18:59
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .